PDS Biotech aims to advance and expand its proprietary pipeline programs independently or in collaboration with renowned research institutions and pharmaceutical companies.
Key commercial partners:
Strategic Research Collaborations with:
PDS Biotech is dedicated to maximizing the full potential of the Versamune® technology in oncology and infectious diseases.
Versamune® is a proprietary T-cell activating platform technology which induces a strong immune response in combination with tailored antigens to more effectively fight disease.
We are open to strategic partnerships which reflect the value-creating potential of Versamune® and provide performance-related downstream revenues, while preserving future growth opportunities for PDS Biotech.